Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 10, 2011, Pages 851-858

  Sofuni, Atsushi ^a   Maguchi, Hiroyuki ^b   Mukai, Tsuyoshi ^c   Kawakami, Hiroshi ^d   Irisawa, Atsushi ^e   Kubota, Kensuke ^f   Okaniwa, Shinji ^g   Kikuyama, Masataka ^h   Kutsumi, Hiromu ⁱ   Hanada, Keiji ^j   Ueki, Toshiharu ^k   Itoi, Takao ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TEINE KEIJINKAI HOSPITAL   (Japan)

^c Gifu Municipal Hospital   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g Iida Municipal Hospital   (Japan)

^h HAMAMATSU ROSAI HOSPITAL   (Japan)

ⁱ KOBE UNIVERSITY   (Japan)

^j Onomichi General Hospital   (Japan)

^k Fukuoka University Chikushi Hospital   (Japan)

more..

Author keywords

Clinical Trial; Drainage; Inflammation; Pancreas

Indexed keywords

ADULT; ARTICLE; CANNULATION; ECHOGRAPHY; ENDOSCOPIC SURGERY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PANCREAS; PANCREAS DUCT STENT; PANCREATITIS; PANCREATOGRAPHY; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STENT;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; INCIDENCE; MALE; PANCREATIC DUCTS; PANCREATITIS; STENTS; TREATMENT OUTCOME;

EID: 80053132165     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.06.033     Document Type: Article

References (32)

1. Freeman M.L., Nalini M., Guda M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004, 59:845-864.
2. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001, 54:425-434.
3. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006, 101:139-147.
4. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996, 335:909-918.
5. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001, 96:417-423.
6. Mehta S.N., Pavone E., Barkun J.S., et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998, 30:457-463.
7. Sherman S., Ruffolo T.A., Hawes R.H., et al. A prospective series with emphasis on the increased risk associates with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991, 101:778-782.
8. Vandervoort J., Soetikno R.M., Tham T.C., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002, 56:652-656.
9. Elton E., Howell D.A., Parsons W.G., et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998, 47:240-249.
10. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc 2003, 57:291-294.
11. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998, 115:1518-1524.
12. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993, 39:652-657.
13. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 2004, 60:544-550.
14. Catalano M.F., Linder J.D., Chak A., et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004, 59:225-232.
15. Tsuchiya T., Itoi T., Sofuni A., et al. A temporary inner unflanged 5Fr pancreatic duct stent to prevent post-ERCP pancreatitis. A preliminary and single center randomized controlled trial study. J Hepatobiliary Pancreat Surg 2007, 14:302-307.
16. Sherman S., Lehman G., Freeman M., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 1997, 92(Suppl 9):1639.
17. Freeman M.L. Role of pancreatic stents in prevention of post-ERCP pancreatitis. Pancreas 2004, 5:322-327.
18. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002, 34:280-285.
19. Aizawa T., Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001, 54:209-213.
20. Freeman M.L., Overby C., Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004, 59:8-14.
21. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999, 49:322-327.
22. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37:383-393.
23. Tarnasky P., Cunningham J., Cotton P., et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997, 29:252-257.
24. Sherman S., Troiano F.P., Hawes R.H., et al. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990, 36:462-466.
25. Rashdan A., Fogel E.L., Mchenry L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004, 2:322-329.
26. Sofuni A., Maguchi H., Itoi T., et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007, 5:1339-1346.
27. Dumonceau J.M., Deviere J., Cremer M. A new method of achieving deep cannulation of the common bile duct during endoscopic retrograde cholangiopancreatography. Endoscopy 1998, 30:S80.
28. Ito K., Fujita N., Noda Y., et al. Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography. World J Gastroenterol 2008, 14:5595-5600.
29. Mazaki T., Masuda H., Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010, 42:842-853.
30. Dumonceau J.M., Andriulli A., Deviere J., et al. European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010, 42:503-515.
31. Chahal P., Tarnasky P.R., Petersen B.T., et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009, 7:834-839.
32. Testoni P.A., Mariani A., Giussani A., et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol 2010, 105:1753-1761.